 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| Enrollment open, Metastases: First in Human Study of TORL-3-600 in Participants With Advanced Cancer (clinicaltrials.gov) - Oct 3, 2023
P1, N=70, Recruiting, Sponsor: TORL Biotherapeutics, LLC
Not yet recruiting --> Recruiting
- ||| New P1 trial, Metastases: First in Human Study of TORL-3-600 in Participants With Advanced Cancer (clinicaltrials.gov) - Jul 17, 2023
P1, N=70, Not yet recruiting, Sponsor: TORL Biotherapeutics, LLC
- ||| TORL-2-307-ADC / TORL Biotherap
Review: TORL-2-307-ADChttps://www.adcreview.com/drugmap/torl-2-307-adc/ (Twitter) - Sep 19, 2022
- ||| TORL-2-307-ADC / TORL Biotherap
Enrollment open, Metastases: First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer (clinicaltrials.gov) - Feb 28, 2022
P1, N=70, Recruiting, Sponsor: TORL Biotherapeutics, LLC
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| TORL-2-307-ADC / TORL Biotherap
New P1 trial, Metastases: First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer (clinicaltrials.gov) - Dec 13, 2021
P1, N=70, Not yet recruiting, Sponsor: TORL Biotherapeutics, LLC